Sort   by:  
 Page size 
UnknownMechanistic basis and efficacy of targeting the β-catenin-TCF7L2-JMJD6-c-Myc axis to overcome resistance to BET inhibitors.
Not available
S-EPMC7146021 | biostudies-literature
UnknownClearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.
Not available
S-EPMC6008108 | biostudies-literature
UnknownAlcohol brief intervention for hospitalized veterans with hazardous drinking: protocol for a 3-arm randomized controlled efficacy trial.
Not available
S-EPMC4480647 | biostudies-literature
Unknown6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150).
Not available
S-EPMC8486817 | biostudies-literature
TranscriptomicsTranscription profiling of whole testis from wild type, bgcn- and Os+bgcn- Drosophila
Whole testes were dissected from adult males. RNA from five or six biological replicates were generated and the expression profiles were determined using Affymetrix Drosophila Genechip 1 arrays. Comparisons between the bgcn- and Os+bgcn- groups allowed for the identification of stem cell genes.
ORGANISM(S): Drosophila melanogaster 
2007-06-28 | E-GEOD-4188 | biostudies-arrayexpress
ProteomicsEffect of CDK7 inhibitor on protein expression alterations in cultured secondary AML HEL92.1.7 cells
HEL92.1.7 cells in exponential growth phase were treated with 100 nM of SY-5609 for 24 hours to determine the global protein expression alterations that correlate with the cell cycle, growth inhibitory and lethal effects of treatment with a CDK7 inhibitor in secondary AML cells.
ORGANISM(S): Homo sapiens (Human) 
2025-04-28 | PXD053572 | Pride
Secondary aml Cdk7 inhibitor C-myc 
UnknownAutomated and customizable quantitative image analysis of whole Caenorhabditis elegans germlines.
Not available
S-EPMC8045727 | biostudies-literature
UnknownA phase 2 study of pracinostat combined with ruxolitinib in patients with myelofibrosis.
Not available
S-EPMC6594864 | biostudies-literature
UnknownManagement of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report.
Not available
S-EPMC11647623 | biostudies-literature
UnknownVenetoclax-based therapies for acute myeloid leukemia.
Not available
S-EPMC6581210 | biostudies-literature
Sort   by:  
 Page size